Gradientech

Gradientech AB is a Swedish life science and diagnostics company based in Uppsala, specializing in ultra-rapid antibiotic susceptibility testing (AST) systems and next-generation diagnostics for infectious diseases. The company focuses on precision medicine and develops microscale tools and patented microfluidic platforms that allow for live imaging and analysis of cell behavior in response to concentration gradients. This technology is particularly useful for measuring minimum inhibitory concentration (MIC) values in clinical microbiology. The flagship product, QuickMIC®, is designed for rapid antibiotic susceptibility testing, providing clinicians with precise MIC values quickly. This enables faster treatment decisions for infections, such as sepsis, and aims to reduce healthcare costs while combating antibiotic resistance. Gradientech serves clinical microbiology laboratories and healthcare providers, emphasizing the importance of timely and reliable diagnostic solutions. The company operates under a quality management system certified to ISO 13485 and is recognized for its innovative contributions to the life science sector.

• Employees 36
• Founded 2009
• Annual Revenue $5000000
• Total Funding $15856502